Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.64 |
| ▸ | IGF2R | P11717 | 4/20 | 0.57 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.47 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.46 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.46 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.44 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoribosyl Pyrophosphate SCHEMBL21330 | 1.00 | FBP1 (0.64) | FBP1IGF2RAMDHD2P2RY14B4GALT1 | |
| Phosphoribosyl Pyrophosphate SCHEMBL28174133 | 1.00 | FBP1 (0.64) | FBP1IGF2RAMDHD2P2RY14B4GALT1 | |
| Phosphoribosyl Pyrophosphate SCHEMBL28209513 | 1.00 | FBP1 (0.64) | FBP1IGF2RAMDHD2P2RY14B4GALT1 | |
| Phosphoribosyl Pyrophosphate SCHEMBL16018854 | 1.00 | FBP1 (0.64) | FBP1IGF2RAMDHD2P2RY14B4GALT1 | |
| Phosphoribosyl Pyrophosphate SCHEMBL30360449 | 0.98 | FBP1 (0.62) | FBP1IGF2RAMDHD2P2RY14B4GALT1 | |
| SCHEMBL1332683 | 0.87 | FBP1 (0.72) | FBP1IGF2RAMDHD2P2RY2 | |
| SCHEMBL1702604 | 0.87 | FBP1 (0.72) | FBP1IGF2RAMDHD2P2RY2 | |
| SCHEMBL3504366 | 0.86 | FBP1 (0.66) | FBP1IGF2RAMDHD2P2RY14B4GALT1 | |
| SCHEMBL18710785 | 0.85 | FBP1 (0.70) | FBP1IGF2RAMDHD2P2RY14B4GALT1 | |
| SCHEMBL8847405 | 0.85 | FBP1 (0.70) | FBP1IGF2RAMDHD2P2RY14B4GALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 978 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121825925-B | Beta 1, 4-galactosyltransferase Habeta 4GalT-S233P and application thereof in synthesis of LNnT | 中国海洋大学 | 2026-05-12 | — | — | CN | claimed |
| WO-2026042726-A1 | EMBRYO ACQUISITION METHOD | 学校法人金沢医科大学 | 2026-02-26 | — | — | WO | claimed |
| CN-119979435-A | Method for improving yield of escherichia coli L-carnosine by increasing PRPP supply | 北京绿色康成生物技术有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119955700-A | Xanthosine production strain and construction method and application thereof | 天津科技大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119899883-A | Method for preparing NMN | 叁爻生物科技(上海)有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119776389-A | Recombinant strain for producing nicotinamide mononucleotide and application thereof | 深圳瑞德林生物技术有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025068276-A2 | A BIOCATALYTIC ROUTE TO INDOLE, AND OPTIONALLY INDICAN AND/OR INDIGO | DANMARKS TEKNISKE UNIVERSITET (DK) | 2025-04-03 | — | — | WO | claimed |
| CN-119220474-B | Escherichia coli genetically engineered bacterium for producing L-histidine through fermentation, method and application | 天津科技大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119391609-A | Construction and use of strain for producing pseudouridine | 汝州市坤和生物科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| WO-2011034263-A1 | METHOD FOR PREDICTING A DRUG TARGET IN PATHOGENIC MICROORGANISMS USING AN ESSENTIAL METABOLITE | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| EP-2235201-A1 | METHODS AND COMPOSITIONS FOR ASSAYING HOMOCYSTEINE | GENERAL ATOMICS (US) | 2010-10-06 | — | — | EP | claimed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | claimed |
| EP-2097743-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | Korea Advanced Institute of Science and Technology (KR) | 2009-09-09 | — | — | EP | claimed |
| WO-2009089106-A1 | METHODS AND COMPOSITIONS FOR ASSAYING HOMOCYSTEINE | GENERAL ATOMICS (US) | 2009-07-16 | — | — | WO | claimed |
| WO-2009018368-A1 | COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2009-02-05 | — | — | WO | claimed |
| US-20080305507-A1 | METHODS AND COMPOSITIONS FOR ASSAYING HOMOCYSTEINE | GENERAL ATOMICS (US) | 2008-12-11 | — | — | US | claimed |
| WO-2008078911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-07-03 | — | — | WO | claimed |
| US-20050221409-A1 | Methods for the identification of inhibitors of amidophosphoribosyltransferase as antibiotics | ICORIA, INC. | 2005-10-06 | — | — | US | claimed |
| WO-2005029034-A2 | METHODS FOR THE IDENTIFICATION OF INHIBITORS OF AMIDOPHOSPHORIBOSYLTRANSFERASE AND CUTINASE TRANSCRIPTION FACTOR 1 AS ANTIBIOTICS | ICORIA, INC. (US) | 2005-03-31 | — | — | WO | claimed |